» Articles » PMID: 30536444

Multimodal Magnetic Resonance Imaging Investigation of Basal Forebrain Damage and Cognitive Deficits in Parkinson's Disease

Overview
Journal Mov Disord
Date 2018 Dec 12
PMID 30536444
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cognitive deficits in Parkinson's disease (PD) may result from damage in the cortex as well as in the dopaminergic, noradrenergic, and cholinergic inputs to the cortex. Cholinergic inputs to the cortex mainly originate from the basal forebrain and are clustered in several regions, called Ch1 to Ch4, that project to the hippocampus (Ch1-2), the olfactory bulb (Ch3), and the cortex and amygdala (Ch4).

Objective: We investigated changes in basal forebrain and their role in cognitive deficits in PD.

Methods: We studied 52 nondemented patients with PD (Hoehn & Yahr 1-2) and 25 age-matched healthy controls using diffusion and resting state functional MRI.

Results: PD patients had a loss of structural integrity within the Ch1-2 and Ch3-4 nuclei of the basal forebrain as well as in the fornix. Tractography showed that the probability of anatomical connection was decreased in PD between Ch3-4 and the associative prefrontal cortex, occipital cortex, and peri-insular regions. There was a reduction in functional connectivity between Ch1-2 and the bilateral hippocampi and parahippocampal gyri, the left middle and superior temporal gyri, and the left fusiform gyrus and between Ch3-4 and the right inferior frontal gyrus and the right and left thalamus. In Ch1-2, loss of structural integrity and connectivity correlated with scores at the memory tests, whereas changes in Ch3-4 correlated with scores of global cognition and executive functions.

Conclusion: This study highlights the association between deficits of different cholinergic nuclei of the basal forebrain and the extent of cognitive impairments in nondemented PD patients. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Citing Articles

Cholinergic Basal Forebrain Integrity and Cognition in Parkinson's Disease: A Reappraisal of Magnetic Resonance Imaging Evidence.

Slater N, Melzer T, Myall D, Anderson T, Dalrymple-Alford J Mov Disord. 2024; 39(12):2155-2172.

PMID: 39360864 PMC: 11657024. DOI: 10.1002/mds.30023.


Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).

Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J Med Int (Lond). 2024; 4(6):70.

PMID: 39355336 PMC: 11443310. DOI: 10.3892/mi.2024.194.


German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.

Kalbe E, Folkerts A, Witt K, Buhmann C, Liepelt-Scarfone I J Neurol. 2024; 271(11):7330-7357.

PMID: 39120709 PMC: 11561078. DOI: 10.1007/s00415-024-12503-0.


Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson's Disease without Dementia.

Santos L, Kenney L, Ray A, Paredes A, Ratajska A, Eversole K Arch Clin Neuropsychol. 2024; 39(8):1443-1449.

PMID: 38797973 PMC: 11586454. DOI: 10.1093/arclin/acae041.


Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.

Jellinger K Int J Mol Sci. 2024; 25(1).

PMID: 38203667 PMC: 10778722. DOI: 10.3390/ijms25010498.


References
1.
Cordes D, Haughton V, Arfanakis K, Carew J, Turski P, Moritz C . Frequencies contributing to functional connectivity in the cerebral cortex in "resting-state" data. AJNR Am J Neuroradiol. 2001; 22(7):1326-33. PMC: 7975218. View

2.
Nichols T, Holmes A . Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2001; 15(1):1-25. PMC: 6871862. DOI: 10.1002/hbm.1058. View

3.
Hanyu H, Asano T, Sakurai H, Tanaka Y, Takasaki M, Abe K . MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol. 2002; 23(1):27-32. PMC: 7975505. View

4.
Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

5.
Aarsland D, Andersen K, Larsen J, Lolk A, Kragh-Sorensen P . Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003; 60(3):387-92. DOI: 10.1001/archneur.60.3.387. View